LCTX
#3339
Lineage Cell Therapeutics, Inc. Common Stock
1.1 7 USD
+0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.54%
Monthly Change
+10.38%
6 month change
-38.42%
Year Change
-31.86%
Previous Close
1.1 3
Open
1.1 7
Low
1.1 6
High
1.1 9
Volume
356
Financials
- Market Capitalization 295.9 M
- Employee 77
- Founded 1990
- CEO N/A
- Website www.lineagecell.com
- Headquarter California, United States
- FIGI BBG000G8RJY6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.96
Price to sales ratio
26.4
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3321 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.97 USD | -2.16% | -3.67% | +29.82% | +8.84% | 301.65 M USD | ||
| 3325 |  TTRX Turn Therapeutics Inc. - Common Stock | 10.11 USD | +4.98% | +4.88% | +32.16% | +1.10% | 301.16 M USD | ||
| 3351 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.85 USD | -0.26% | 0.00% | +4.34% | -42.62% | 293.74 M USD | ||
| 3365 |  AVXL Anavex Life Sciences Corp. - Common Stock | 3.13 USD | -3.40% | -1.57% | +22.27% | -65.98% | 290.06 M USD |
Frequently asked questions about Lineage Cell Therapeutics, Inc.
What is the Lineage Cell Therapeutics, Inc. stock price today?
The current price of Lineage Cell Therapeutics, Inc. (LCTX) is 1.17. Over the past 24 hours, the stock has changed by +3.54%. Follow the LCTX chart for real-time price dynamics.
What is the stock ticker of Lineage Cell Therapeutics, Inc.?
Lineage Cell Therapeutics, Inc. trades under the ticker LCTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Lineage Cell Therapeutics, Inc. stock going up?
LCTX has changed by +7.34% over the last week, +10.38% over the last month, and -31.86% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Lineage Cell Therapeutics, Inc.?
Lineage Cell Therapeutics, Inc. currently has a market capitalization of 295.9 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Lineage Cell Therapeutics, Inc. earnings last quarter?
Last quarter, Lineage Cell Therapeutics, Inc. reported earnings of 0.01 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Lineage Cell Therapeutics, Inc. revenue for the last quarter?
Lineage Cell Therapeutics, Inc. reported quarterly revenue of 1.07 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Lineage Cell Therapeutics, Inc. net income for the last quarter?
Lineage Cell Therapeutics, Inc. reported net income of 1.48 M for the last quarter. The previous quarter showed -4.81 M, which means net income changed by +130.80%.
How many employees does Lineage Cell Therapeutics, Inc. have?
As of the latest available data, Lineage Cell Therapeutics, Inc. has 77 employees. Workforce size can provide additional context about the company's scale and operations.
What is Lineage Cell Therapeutics, Inc. EBITDA?
Lineage Cell Therapeutics, Inc. EBITDA is -8.91 M, and its EBITDA margin is -833.96%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Lineage Cell Therapeutics, Inc. stock?
You can buy Lineage Cell Therapeutics, Inc. (LCTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Lineage Cell Therapeutics, Inc. stock?
Investing in Lineage Cell Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LCTX chart and related analysis on metatrader.com as part of your research.